Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
'We will deliver in 2020,' Cambridge biotech CEO promises after 2nd trial disappointment
07:30pm, Monday, 13'th Jan 2020
Pablo Cagnoni
Head to Head Analysis: Homology Medicines (NASDAQ:FIXX) versus Achaogen (NASDAQ:AKAOQ)
10:42am, Sunday, 12'th Jan 2020
Homology Medicines (NASDAQ:FIXX) and Achaogen (OTCMKTS:AKAOQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their
Cambridge startup raises $110M for re-doseable gene therapies
07:20pm, Friday, 10'th Jan 2020
Generation Bio CEO Geoffrey McDonough.
Here’s Why We’re Not Too Worried About Homology Medicines’s (NASDAQ:FIXX) Cash Burn Situation
06:48pm, Friday, 10'th Jan 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
We're Not Very Worried About Homology Medicines's (NASDAQ:FIXX) Cash Burn Rate
01:01pm, Wednesday, 01'st Jan 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
3 Small-Cap Stocks Ready to Make a Big Splash
03:49pm, Tuesday, 24'th Dec 2019
Everyone has to start somewhere. As is often repeated, today’s biggest companies came from humble beginnings, a garage being the initial home for mega corporations like Microsoft, Amazon and Disney.
Homology Medicines' Gene Therapy For Phenylketonuria Found Safe, Efficacy Data Mixed
03:23pm, Wednesday, 18'th Dec 2019
Shares of genetic therapy company Homology Medicines Inc (NASDAQ: FIXX ) were moving to the downside Wednesday. Homology Medicines Reports Trial Data Bedford, Massachusetts-based Homology announced in
The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
12:23pm, Wednesday, 18'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc
Homology Medicines Announces Encouraging Initial Clinical Data from its pheNIX Gene Therapy Trial for PKU
09:01pm, Tuesday, 17'th Dec 2019
Homology Medicines, Inc. (FIXX), a genetic medicines company, announced today promising initial clinical data from the first gene therapy clinical trial in phenylketonuria (PKU). The pheNIX trial is
Homology Medicines, Inc. (FIXX), a genetic medicines company, announced today a peer-reviewed publication of findings from a five-year retrospective chart review that demonstrated phenylalanine (Phe)
Homology Medicines, Inc. (FIXX): Are Hedge Funds Right About This Stock?
07:44pm, Friday, 13'th Dec 2019
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and
A Base Editing IPO from Beam Therapeutics
05:59am, Tuesday, 01'st Oct 2019
The ability to modify genes may be one of the most promising disruptive technologies there is today. As the general public learns about the potential of gene editing, retail investors will be looki
Analysts Estimate Homology Medicines (FIXX) to Report a Decline in Earnings: What to Look Out for
02:31pm, Monday, 05'th Aug 2019
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Precision BioSciences Stock Offered in IPO
04:47am, Saturday, 09'th Mar 2019
In our recent article on DNA nanotechnology, we looked at a paper co-authored by George Church that refers to the “staggering” progress being made in gene editing. While it used to be that gene
Vor Biopharma Completes $42M Series A Financing | FinSMEs
05:56pm, Thursday, 14'th Feb 2019
Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell therapies to treat hematological malignancies, raised $42m
